• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Adv . CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment

tetano

Editor, Senior Moderator
Sci Adv


. 2024 Aug 23;10(34):eadp2636.
doi: 10.1126/sciadv.adp2636. Epub 2024 Aug 23. CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment

Meenakshi Kar[SUP] 1 2 3 [/SUP], Katherine E E Johnson[SUP] 4 [/SUP], Abigail Vanderheiden[SUP] 5 6 [/SUP], Elizabeth J Elrod[SUP] 2 3 7 [/SUP], Katharine Floyd[SUP] 1 2 3 [/SUP], Elizabeth Geerling[SUP] 8 [/SUP], E Taylor Stone[SUP] 8 [/SUP], Eduardo Salinas[SUP] 2 3 7 [/SUP], Stephanie Banakis[SUP] 4 [/SUP], Wei Wang[SUP] 4 [/SUP], Shruti Sathish[SUP] 4 [/SUP], Swathi Shrihari[SUP] 1 2 3 [/SUP], Meredith E Davis-Gardner[SUP] 1 2 3 [/SUP], Jacob Kohlmeier[SUP] 9 [/SUP], Amelia Pinto[SUP] 8 [/SUP], Robyn Klein[SUP] 10 11 [/SUP], Arash Grakoui[SUP] 2 3 7 [/SUP], Elodie Ghedin[SUP] 4 [/SUP], Mehul S Suthar[SUP] 1 2 3 9 [/SUP]



Affiliations
Abstract

SARS-CoV-2 infection induces the generation of virus-specific CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] effector and memory T cells. However, the contribution of T cells in controlling SARS-CoV-2 during infection is not well understood. Following infection of C57BL/6 mice, SARS-CoV-2-specific CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells are recruited to the respiratory tract, and a vast proportion secrete the cytotoxic molecule granzyme B. Using depleting antibodies, we found that T cells within the lungs play a minimal role in viral control, and viral clearance occurs in the absence of both CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells through 28 days postinfection. In the nasal compartment, depletion of both CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells, but not individually, results in persistent, culturable virus replicating in the nasal epithelial layer through 28 days postinfection. Viral sequencing analysis revealed adapted mutations across the SARS-CoV-2 genome, including a large deletion in ORF6. Overall, our findings highlight the importance of T cells in controlling virus replication within the respiratory tract during SARS-CoV-2 infection.


 
Back
Top Bottom